Critically Ill Neonates and Secondary Genomic Findings.

Secondary genomic findings in critically ill neonates are a subject of debate regarding their clinical reporting and utility.

• Why it matters: Understanding whether to seek and report these findings is crucial because it impacts clinical decision-making and ethical considerations in vulnerable populations like neonates.
• What they did: The authors review the debate surrounding the inclusion of secondary genomic findings in diagnostic sequencing tests for critically ill neonates, emphasizing the lack of consensus.
• The result: Clarifying this issue could guide clinical practices and policies, potentially improving care and ethical standards for neonatal genomic testing.